Before SARS-CoV-2 / COVID-19 testing begins, laboratories that are CLIA-certified and able to perform testing should consider:
- Performing a site-specific and activity-specific risk assessment to identify and mitigate safety risks.
- Training on the proper use of testing related instrument(s) and equipment, including how to decontaminate after use with an appropriate disinfectant.
- Using testing instrument(s), including point of care tests, in a location associated with a current CLIA certificate.
- Training for ways to minimize the risk of exposures and how to follow response plans if there is a potential exposure event.
- Training staff how to follow standard precautions when handling clinical specimens, including hand hygiene, the use of personal protective equipment (PPE), or any additional precautions that were determined by the laboratory’s risk assessment.
The CDC provides COVID-19 specific testing guidelines available
here.
10. Gathany, James. "These two Centers for Disease Control and Prevention (CDC) scientists were analyzing and discussing SARS-CoV-2 diagnostic test results." CDC.gov, 2020, https://phil.cdc.gov/Details.aspx?pid=23901
